The low expression of PDLIM2 in lung cancer promotes the malignant progression of tumors, and the mechanism may be related to mitochondrial dysfunction and tumor metabolite accumulation caused by the increase of mitochondrial reactive oxygen species (ROS) (Yang J. X. et al., 2024). Here, PDLIM2 is linked to lung carcinoma.